AstraZeneca’s test drug for breast cancer fails to prolong life
HQ Team September 13, 2026: AstraZeneca’s end-stage trial of an experimental drug to treat breast cancer failed to prolong a patient’s life without
HQ Team September 13, 2026: AstraZeneca’s end-stage trial of an experimental drug to treat breast cancer failed to prolong a patient’s life without
HQ Team September 11, 2026: AbbVie Inc.’s experimental drug has reduced the number of migraine days during the menstrual period, meeting a key
HQ Team September 11, 2026: A measles outbreak in the South Asian nation of Bangladesh, which has killed nearly 1,000 people, is a
HQ Team September 10, 2026: A team of neurosurgeons, medical robotics specialists, and advanced energy systems engineers is building a device that uses
HQ Team September 9, 2026: Novartis AG’s experimental drug to treat a neuromuscular disease failed to meet its target, the company announced. The
HQ Team August 21, 2026: The International Coordinating Group on Vaccine Provision (ICG), a coalition of health groups including the World Health Organization,
HQ Team August 20, 2026: Moderna’s stock more than doubled, surging as much as 177% intraday to $174.38 on Aug. 19, 2026, after
HQ Team August 20, 2026: Nearly 7% of deaths among U.S. flight attendants and pilots are linked to radiation-related cancers — the highest
HQ Team August 19, 2026: In conflict-ridden Gaza, just 3% of cropland remains usable to grow food as Israeli troops pound the region
HQ Team August 19, 2026: An epidemic caused by the Bundibugyo virus will continue to spread in the central African country of Congo